Dr. Woods’ primary research interests lie in the application of cognitive models of language (e.g., verb generation) and memory (e.g., prospective memory) to examine the effects of HIV-1 infection and substance abuse on cognition and everyday functioning outcomes (e.g., medication adherence).
Dr. Stein’s major area of expertise lies in the anxiety disorders, which he studies using a range of methods, including animal models, brain imaging, neurogenetics, and epidemiological surveys.
As Chair of the Department of Psychiatry, he is increasingly interested in mentoring individuals who are contributing to research areas particularly relevant to South Africa, including neuroHIV and substance use disorders. This has led to a range of collaborations in such areas as brain imaging of neuroHIV and substance use disorders.
Dr. Svetlana Semenova’s main research focus is investigating the risk factors and neurobiological mechanisms that contribute to the development of dependence to various drugs of abuse (methamphetamine, nicotine, cocaine, alcohol) using rodent animal models. The risk factors of interest include individual differences in sensitivity to drugs of abuse and trait impulsivity as well as comorbid disorders such as schizophrenia, depression and HIV.
Dr. Martin’s research career has focused primarily on the neurocognitive mechanisms and specific effects of HIV on the brain and predictors of vulnerability to HIV-associated neurocognitive impairment among men and women with a history of drug dependence.
Dr. Ling is Professor of Psychiatry and Director of Integrated Substance Abuse Programs (ISAP) at UCLA, one of the foremost substance abuse research groups in the US and worldwide. He is board certified in neurology and psychiatry, is active in research and clinical work, and has been listed in “Best Doctors in America”, “Best Doctors in the West” and “Best Doctors in Los Angeles”.
Dr. Kaul’s laboratory studies at the cellular and molecular level how infections, co-morbidity factors, such as drug abuse, and the responding immune system can induce inflammation and degenerative diseases.
Dr. Chang has many ongoing research studies, and collaborates extensively with other investigators, on clinical and translational research in neurological complications of HIV and drug abuse. She also leads projects that involve normal and abnormal brain development and brain aging, such as those involved in neonates and children with drug exposure or HIV infection.
Dr. Buch’s research activities include the examination of drugs abuse and HIV/SIV cooperativity, the assessment of chemokine connection and the study of endogenous neuroprotective pathways.